JMP Securities raised the firm’s price target on American Healthcare REIT to $18 from $16 and keeps an Outperform rating on the shares. American Healthcare REIT reported strong Q2 results, reflecting higher other income and better NOI margin in the company’s Trilogy and SHOP portfolios, the analyst tells investors in a research note. The firm sees the shares as attractively valued and believes multiple expansion should occur as the company naturally de-levers through the recovery of this portfolio.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT Releases Q2 Supplemental Data
- American Healthcare REIT raises FY24 NFFO view to $1.23-$1.27 from $1.18-$1.24
- American Healthcare REIT reports Q2 normalized FFO 33c, consensus 29c
- American Healthcare REIT (“AHR”) Announces Second Quarter 2024 Results; Increases Full Year 2024 Guidance
- AHR Earnings this Week: How Will it Perform?